Human CCL17/TARC Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDDN00
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (50 µL), Serum (50 µL), EDTA Plasma (50 µL), Heparin Plasma (50 µL)
• Sensitivity: 7 pg/mL
• Range: 31.2 - 2,000 pg/mL (Serum, Heparin Plasma, Cell Culture Supernates, EDTA Plasma)
• Format: 96-well strip plate
• Description: The Quantikine Human TARC Immunoassay kit is a 3.5 hour solid phase ELISA designed to measure TARC in cell culture supernates, serum, and plasma
• Gene: CCL17

Product References

Prognostic significance of pretreatment serum cytokines in classical Hodgkin - Prognostic significance of pretreatment serum cytokines in classical Hodgkin

Marri PR, Hodge LS, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link BK, Cerhan JR, Novak AJ, Ansell SM. Clin Cancer Res. 2013 Dec 15;19(24):6812-9.

Regulatory T cells suppress T cell activation at the pathologic site of human - Regulatory T cells suppress T cell activation at the pathologic site of human

Rai AK, Thakur CP, Singh A, Seth T, Srivastava SK, Singh P, Mitra DK. PLoS One. 2012;7(2):e31551.

Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of - Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of

Oo YH, Weston CJ, Lalor PF, Curbishley SM, Withers DR, Reynolds GM, Shetty S, Harki J, Shaw JC, Eksteen B, Hubscher SG, Walker LS, Adams DH. J Immunol. 2010 Mar 15;184(6):2886-98.

Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant - Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant

Roufosse F, de Lavareille A, Schandene L, Cogan E, Georgelas A, Wagner L, Xi L, Raffeld M, Goldman M, Gleich GJ, Klion A. J Allergy Clin Immunol. 2010 Oct;126(4):828-835.e3. doi:

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. - Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, Forero-Torres A. N Engl J Med. 2010 Nov 4;363(19):1812-21.

Increases in serum TARC/CCL17 levels are associated with progression-free - Increases in serum TARC/CCL17 levels are associated with progression-free

Cornforth AN, Lee GJ, Fowler AW, Carbonell DJ, Dillman RO. J Clin Immunol. 2009 Sep;29(5):657-64.

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. - Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DY. J Allergy Clin Immunol. 2009 Aug;124(2):260-9, 269.e1-7. doi:

The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one - The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one

Narbutt J, Lesiak A, Sysa-Jedrzeiowska A, Zakrzewski M, Bogaczewicz J, Stelmach I, Kuna P. Mediators Inflamm. 2009;2009:269541.

Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: - Development of an in vitro potency bioassay for therapeutic IL-13 antagonists:

Miller R, Sadhukhan R, Wu C. J Immunol Methods. 2008 May 20;334(1-2):134-41.

In vitro induction of a dendritic cell phenotype in primary human acute - In vitro induction of a dendritic cell phenotype in primary human acute

Olsnes AM, Ryningen A, Ersvaer E, Bruserud O. J Interferon Cytokine Res. 2008 May;28(5):297-310.